Sort
40,608 grants matching “prostate cancer”
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer
$481,793Christopher J Sweeney · Dana-Farber Cancer Inst · R01 · FY2017 · CA
Cooperativity of TMPRSS2-ERG fusion with p53 inactivation in prostate cancer pathogenesis
$481,745Liewei Wang · Mayo Clinic Rochester · R01 · FY2023 · CA
Non-coding RNAs for Epigenetic Transcriptional Silencing in Prostate Cancer
$481,734Martin John Walsh · Icahn School Of Medicine At Mount Sinai · R01 · FY2012 · CA
Understanding the role of an aberrant hepatic nuclear transcription circuit in prostate cancer tumorigenesis and castration resistance
$481,696Yu Chen · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Breaking down tumor immune privilege through targeted hypoxia reduction
$481,691Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Breaking down tumor immune privilege through targeted hypoxia reduction
$481,691Michael A. Curran · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
TECHNETIUM AND RHENIUM IN NUCLEAR MEDICINE
$481,629Harvard University (Medical School) · R01 · FY2001 · CA
The Molecular Profile of Prostate Tumors in African-American Men
$481,515Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Deciphering the molecular mechanisms of histone code recognition by ATAD2/B
$481,491Karen Champagne Glass · Albany College Of Pharmacy · R01 · FY2020 · GM
Hybrid Plasma Markers that Complement CT Imaging for Early Lung Cancer Detection
$481,475Paul D Lampe · Fred Hutchinson Cancer Research Center · U01 · FY2018 · CA
Genotypic and Phenotypic Studies of Inflammation in PCPT
$481,452Scott M Lippman · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
Nitric Oxide as a Modifier of Oxidative Stress
$481,426David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
Atlases to Report and Correlate Radiotherapy Dose Distributions with Outcomes
$481,389Andrew Jackson · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$481,339Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Translation and Evaluation of a Multiparametric Prostate Cancer 3T Exam
$481,279John Kurhanewicz · University Of California, San Francisco · R01 · FY2014 · CA
Development of SHP2 inhibitors for targeted anti-cancer therapy
$481,271Zhong-Yin Zhang · Purdue University · R01 · FY2017 · CA
Bay Area Tumor Institute CCOP
$481,201James Feusner · Bay Area Tumor Institute · U10 · FY2008 · CA
Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma
$481,094David Paul Turner · Virginia Commonwealth University · R01 · FY2023 · CA
Resolving ensemble averaged conformations by multi-temperature x-ray crystallography
$481,088James Solomon Fraser · University Of California, San Francisco · R01 · FY2018 · GM
INVESTIGATING ARHGEF2 IN PROMOTING NEURAL LINEAGE PLASTICITY AND TREATMENT RESISTANCE IN ADVANCED PROSTATE CANCER
$481,056University Of California, Davis · · FY2025 · Defense Health Agency
Clinical Translation of a Large Oncosome-Based Prostate Cancer Blood Test
$480,986Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Greater Denver Latino Cancer Prevention/Control Network
$480,951Estevan Tim Flores · University Of Colorado Denver · U01 · FY2006 · CA
A novel strategy to overcome drug resistance in cancer
$480,820Aimee L Edinger · University Of California-Irvine · R01 · FY2023 · CA
INVESTIGATION OF THE UBIQUITIN LIGASE RNF31 AS A MEDIATOR OF IMMUNE EVASION IN ADVANCED PROSTATE CANCER
$480,640Regents Of The University Of California, San Francisco, The · · FY2022 · Defense Health Agency
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$480,634James K Turkson · University Of Hawaii At Manoa · R01 · FY2016 · CA